279 related articles for article (PubMed ID: 12812991)
1. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
2. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
3. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
Pan GY; Liu XD; Liu GQ
Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier opening with alkylglycerols: Biodistribution of 1-O-pentylglycerol after intravenous and intracarotid administration in rats.
Erdlenbruch B; Kugler W; Schinkhof C; Neurath H; Eibl H; Lakomek M
J Drug Target; 2005 Apr; 13(3):143-50. PubMed ID: 16036302
[TBL] [Abstract][Full Text] [Related]
7. Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats.
Erdlenbruch B; Jendrossek V; Eibl H; Lakomek M
Exp Brain Res; 2000 Dec; 135(3):417-22. PubMed ID: 11146820
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
9. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
Inamura T; Black KL
J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
[TBL] [Abstract][Full Text] [Related]
11. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis.
Hasegawa H; Allen JC; Mehta BM; Shapiro WR; Posner JB
Neurology; 1979 Sep; 29(9 Pt 1):1280-6. PubMed ID: 573408
[TBL] [Abstract][Full Text] [Related]
13. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
Cosolo W; Christophidis N
Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
[TBL] [Abstract][Full Text] [Related]
15. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
16. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
18. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells.
Hülper P; Veszelka S; Walter FR; Wolburg H; Fallier-Becker P; Piontek J; Blasig IE; Lakomek M; Kugler W; Deli MA
Br J Pharmacol; 2013 Aug; 169(7):1561-73. PubMed ID: 23617601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
